Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» prurigo nodularis
prurigo nodularis
Incyte, itching for a piece of Dupixent's market, hits goals in midphase skin disease trial
Fierce Biotech
Mon, 03/11/24 - 11:52 am
Incyte
clinical trials
prurigo nodularis
povorcitinib
Dupixent
Sanofi
Regeneron
Dupixent nears EU approval for rare skin disease prurigo nodularis
Pharmaphorum
Mon, 11/14/22 - 10:52 am
Sanofi
Regeneron
Dupixent
Europe
prurigo nodularis
FDA approves Sanofi and Regeneron’s Dupixent to treat prurigo nodularis
Pharmaceutical Business Review
Thu, 09/29/22 - 10:05 am
Sanofi
Regeneron
Dupixent
prurigo nodularis
FDA
FDA grants speedy review to Dupixent rare skin disease
Pharmaforum
Tue, 05/31/22 - 10:43 am
Sanofi
Regeneron
Dupixent
prurigo nodularis
FDA
Dupixent scores a first in rare skin disease prurigo nodularis
Pharmaforum
Fri, 10/22/21 - 11:22 am
Sanofi
Regeneron
Dupixent
prurigo nodularis